Euglycemic Clamp Dose-response Study Comparing a New Insulin Glargine Formulation With Lantus®

Clinical trial NCT01195454 · COMPLETED

Trial details

NCT number: NCT01195454
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus

Start date: 2010-08-01
Primary completion: 2010-11-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.